logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

暴跌47%后,联合健康的“护城河”还管用吗?

Hims & Hers and Intuitive Surgical Diverge on Growth Paths, Investors Must Weigh Risk Against Valuation

Nov 7, 2026

Life Science

Moderna Returns to Profit After Two Years, Sparking Valuation Debate on 720% 2026 Surge

Moderna Returns to Profit After Two Years, Sparking Valuation Debate on 720% 2026 Surge

Nov 6, 2026

Life Science

福泰制药股价回调:危机还是机遇?

Vertex Pharmaceuticals’ Core Business Grows Steadily, Diversified Layout Begins to Show Results

Nov 6, 2026

Life Science

AI驱动未来医疗,BioNTech股价应声上涨近4%

Moderna Soars Over 600% This Year, Personalized Cancer Vaccine Becomes Key Catalyst

Nov 3, 2026

Life Science

Buffett’s UnitedHealth Bet Pays Off as Insurer Crushes Q1 Estimates

CVS Health Reportedly Plans to Split into Two Independent Entities as Business Restructuring Rumors Materialize

Nov 3, 2026

Life Science

拓展女性健康新领域,Hims & Hers市值一日激增

Eli Lilly Posts Strong Quarterly Results and Hits Record High Stock Price

Nov 2, 2026

Life Science

辉瑞巨资收购Metsera,重塑减肥药赛道的关键布局

Kimberly-Clark Completes Acquisition of Kenvue, Creating a Consumer Goods Giant

Nov 2, 2026

Life Science

AbbVie, a Dividend King, Builds Its Next Blockbuster as ABBV-466 Hits Phase 2 Milestone

AbbVie, a Dividend King, Builds Its Next Blockbuster as ABBV-466 Hits Phase 2 Milestone

Nov 2, 2026

Life Science

拓展女性健康新领域,Hims & Hers市值一日激增

Merck’s Q3 Results Beat Expectations on Both Top and Bottom Lines, Multiple Institutions Raise Target Prices

Oct 30, 2026

Life Science

沃尔玛与强生,抵御经济衰退的两大“股息王”

Johnson & Johnson Raises Guidance Despite Litigation Pressure, Highlighting the Resilience of a Healthcare Giant

Oct 30, 2026

Life Science

百时美施贵宝押注未来,哪些管线将成为新增长支柱?

Bristol Myers Squibb Raises Full-Year Revenue Guidance as New Drugs Offset Patent Expiry Pressure on Older Drugs

Oct 30, 2026

Life Science

GLP-1减肥药竞赛中,诺和诺德股价逆势大涨5%

Novo Nordisk Shares Fall Over 60%, Can Its 2030 Targets Help Drive a Recovery?

Oct 30, 2026

Life Science

股价回调下的机遇?解码礼来的护城河与增长潜力

Boston Scientific Faces Cyber Incident and Product Pressures, With Growth Expected to Be Flat in 2027

Oct 28, 2026

Life Science

Vertex Pharmaceuticals在股市表现亮眼

Jazz Pharmaceuticals Accelerates Oncology Business Layout, Can It Reverse the Growth Slump

Oct 28, 2026

Life Science

特朗普药品关税政策对礼来公司的影响分析

Eli Lilly Sets Trillion-Dollar Market Cap Record as Opportunities and Risks Emerge Together

Oct 28, 2026

Life Science

After a Blistering Rally, Is Revolution Medicines Still a Compelling Value Play?

After a Blistering Rally, Is Revolution Medicines Still a Compelling Value Play?

Oct 27, 2026

Life Science

百时美施贵宝押注未来,哪些管线将成为新增长支柱?

Bristol Myers Squibb Licenses In Anticancer Drug That Extends Progression-Free Survival, Why Investors Reacted Mutedly

Oct 26, 2026

Life Science

ESMO Readouts Steal the Spotlight, These Three Oncology Stocks Don't Need the Podium

ESMO Readouts Steal the Spotlight, These Three Oncology Stocks Don’t Need the Podium

Oct 26, 2026

Life Science

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada